Curis (CRIS) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Curis (CRIS) Tops Q4 EPS by 2c

Curis Reports Fourth Quarter and Year-End 2015 Financial Results

February 29, 2016 7:00 AM EST

LEXINGTON, Mass., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today reported its financial results for the fourth quarter and year ended December 31, 2015.

"2015 has been a year of significant milestones for Curis, said Ali Fattaey, Ph.D., Curis' President and CEO. During the fourth quarter, we presented data from the Phase 1 trial of CUDC-907 at the American Society of Hematologys annual meeting, including notable results from heavily pre-treated patients with DLBCL who... More